Eravacycline

(Xerava)

Eravacycline

Drug updated on 11/15/2023

Dosage FormInjection (intravenous; 1 mg/kg, 1.5 mg/kg)
Drug ClassTetracycline class antibacterials
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For treatment of complicated intra-abdominal infections in adults ≥18 years of age.

Product Monograph / Prescribing Information

Document TitleYearSource
Xerava (eravacycline) Prescribing Information. 2021Tetraphase Pharmaceuticals Inc, Watertown, MA

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines